Literature DB >> 23216065

Avoidable mortality in people with schizophrenia or bipolar disorder in England.

U Hoang1, M J Goldacre, R Stewart.   

Abstract

OBJECTIVE: To quantify the extent of 'avoidable mortality' in those with schizophrenia or bipolar disorder and to quantify the effect a reduction in these might have on the mortality gap associated with severe mental illness.
METHOD: A cohort was studied of people aged <75 years, discharged from inpatient care with schizophrenia or bipolar disorder in 2006-2007, and followed up for 365 days. Standardised mortality ratios (SMRs) were calculated followed by hypothetical SMRs, estimating the residual mortality gap if 'avoidable' causes and suicide in the cohorts had occurred at the same level as those in the general population.
RESULTS: Avoidable deaths comprised 60.2% and 59.2% of all deaths in the schizophrenia and bipolar disorder cohorts respectively. All-cause SMRs were 4.23 (95% CI 3.85-4.60) and 2.60 (2.21-3.00) respectively. After discounting the excess attributable to avoidable causes and suicide, the SMRs fell to 2.38 (2.09-2.66) and 1.66 (1.35-1.98) respectively.
CONCLUSION: Bringing mortality from avoidable causes and suicide down to general population levels would reduce the overall mortality excess in severe mental illness substantially, by about 50%, but would not eliminate it. Other underlying factors beyond those conventionally considered as 'avoidable' need further research.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23216065     DOI: 10.1111/acps.12045

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  30 in total

1.  Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.

Authors:  Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

2.  Health care disparities among persons with comorbid schizophrenia and cardiovascular disease: a case-control epidemiological study.

Authors:  G Gal; H Munitz; I Levav
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-01       Impact factor: 6.892

3.  The iHOPE-20 study: mortality in first episode psychosis-a 20-year follow-up of the Dublin first episode cohort.

Authors:  Roisin Doyle; Donal O'Keeffe; Ailish Hannigan; Anthony Kinsella; Caragh Behan; Aine Kelly; Ann Sheridan; Kevin Madigan; Elizabeth Lawlor; Mary Clarke
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-09       Impact factor: 4.328

4.  Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder.

Authors:  Camila N C Lima; Robert Suchting; Giselli Scaini; Valeria A Cuellar; Alexandra Del Favero-Campbell; Consuelo Walss-Bass; Jair C Soares; Joao Quevedo; Gabriel R Fries
Journal:  Eur Neuropsychopharmacol       Date:  2022-07-08       Impact factor: 5.415

5.  The impact of comorbid severe mental illness and common chronic physical health conditions on hospitalisation: A systematic review and meta-analysis.

Authors:  Naomi Launders; Kate Dotsikas; Louise Marston; Gabriele Price; David P J Osborn; Joseph F Hayes
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

6.  Health Care and Mortality among Persons with Severe Mental Illness.

Authors:  Gilad Gal; Hanan Munitz; Itzhak Levav
Journal:  Can J Psychiatry       Date:  2016-09-24       Impact factor: 4.356

7.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

Authors:  Davy Vancampfort; Brendon Stubbs; Alex J Mitchell; Marc De Hert; Martien Wampers; Philip B Ward; Simon Rosenbaum; Christoph U Correll
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

8.  Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis.

Authors:  Davy Vancampfort; Christoph U Correll; Britta Galling; Michel Probst; Marc De Hert; Philip B Ward; Simon Rosenbaum; Fiona Gaughran; John Lally; Brendon Stubbs
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

9.  Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study.

Authors:  Wing Chung Chang; Joe Kwun Nam Chan; Corine Sau Man Wong; JoJo Siu Han Hai; Philip Chi Fai Or; Eric Yu Hai Chen
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 10.  Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Toby Pillinger; Katherine Beck; Cristian Gobjila; Jacek G Donocik; Sameer Jauhar; Oliver D Howes
Journal:  JAMA Psychiatry       Date:  2017-03-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.